Figure 2a.
Lung injury score in each experimental group at 48 h (A: adalimumab, T: tocilizumab, P: prednisolone) (*: p < 0.001 vs. control, #: p < 0.05 vs. LPS group).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.